149 related articles for article (PubMed ID: 38252848)
1. Does Emotional Distress Predict Worse Glycemic Control Over Time? Results From the Glycemia Reduction Approaches in Diabetes: A Comparative Effectiveness Study (GRADE).
Cherrington AL; Bebu I; Krause-Steinrauf H; Hoogendoorn CJ; Crespo-Ramos G; Presley C; Naik AD; Balasubramanyam A; Gramzinski MR; Killean T; Arends VL; Gonzalez JS;
Diabetes Care; 2024 Apr; 47(4):620-628. PubMed ID: 38252848
[TBL] [Abstract][Full Text] [Related]
2. Emotional Distress Predicts Reduced Type 2 Diabetes Treatment Adherence in the Glycemia Reduction Approaches in Diabetes: A Comparative Effectiveness Study (GRADE).
Hoogendoorn CJ; Krause-Steinrauf H; Uschner D; Wen H; Presley CA; Legowski EA; Naik AD; Golden SH; Arends VL; Brown-Friday J; Krakoff JA; Suratt CE; Waltje AH; Cherrington AL; Gonzalez JS;
Diabetes Care; 2024 Apr; 47(4):629-637. PubMed ID: 38227900
[TBL] [Abstract][Full Text] [Related]
3. Emotional distress, self-management, and glycemic control among participants enrolled in the glycemia reduction approaches in diabetes: A comparative effectiveness (GRADE) study.
Gonzalez JS; Krause-Steinrauf H; Bebu I; Crespo-Ramos G; Hoogendoorn CJ; Naik AD; Waltje A; Walker E; Ehrmann D; Brown-Friday J; Cherrington A;
Diabetes Res Clin Pract; 2023 Feb; 196():110229. PubMed ID: 36549506
[TBL] [Abstract][Full Text] [Related]
4. Differential Effects of Type 2 Diabetes Treatment Regimens on Diabetes Distress and Depressive Symptoms in the Glycemia Reduction Approaches in Diabetes: A Comparative Effectiveness Study (GRADE).
Gonzalez JS; Bebu I; Krause-Steinrauf H; Hoogendoorn CJ; Crespo-Ramos G; Presley C; Naik AD; Kuo S; Johnson ML; Wexler D; Crandall JP; Bantle AE; Arends V; Cherrington AL;
Diabetes Care; 2024 Apr; 47(4):610-619. PubMed ID: 38416773
[TBL] [Abstract][Full Text] [Related]
5. Association of Baseline Factors With Glycemic Outcomes in GRADE: A Comparative Effectiveness Randomized Clinical Trial.
Garvey WT; Cohen RM; Butera NM; Kazemi EJ; Younes N; Rosin SP; Suratt CE; Ahmann A; Hollander PA; Krakoff J; Martin CL; Seaquist E; Steffes MW; Lachin JM;
Diabetes Care; 2024 Apr; 47(4):562-570. PubMed ID: 38285957
[TBL] [Abstract][Full Text] [Related]
6. Baseline Characteristics of Randomized Participants in the Glycemia Reduction Approaches in Diabetes: A Comparative Effectiveness Study (GRADE).
Wexler DJ; Krause-Steinrauf H; Crandall JP; Florez HJ; Hox SH; Kuhn A; Sood A; Underkofler C; Aroda VR;
Diabetes Care; 2019 Nov; 42(11):2098-2107. PubMed ID: 31391203
[TBL] [Abstract][Full Text] [Related]
7. Emotional distress and cardiovascular disease risk among participants enrolled in the Glycemia Reduction Approaches in Diabetes: A Comparative Effectiveness (GRADE) study.
Crespo-Ramos G; Bebu I; Krause-Steinrauf H; Hoogendoorn CJ; Fang R; Ehrmann D; Presley C; Naik AD; Katona A; Walker EA; Cherrington A; Gonzalez JS;
Diabetes Res Clin Pract; 2023 Sep; 203():110808. PubMed ID: 37394014
[TBL] [Abstract][Full Text] [Related]
8. The association of depressive symptoms and diabetes distress with glycaemic control and diabetes complications over 2 years in newly diagnosed type 2 diabetes: a prospective cohort study.
Ismail K; Moulton CD; Winkley K; Pickup JC; Thomas SM; Sherwood RA; Stahl D; Amiel SA
Diabetologia; 2017 Oct; 60(10):2092-2102. PubMed ID: 28776084
[TBL] [Abstract][Full Text] [Related]
9. Metabolic memory: Evolving concepts.
Misra A; Bloomgarden Z
J Diabetes; 2018 Mar; 10(3):186-187. PubMed ID: 29091343
[TBL] [Abstract][Full Text] [Related]
10. Rationale and design of the glycemia reduction approaches in diabetes: a comparative effectiveness study (GRADE).
Nathan DM; Buse JB; Kahn SE; Krause-Steinrauf H; Larkin ME; Staten M; Wexler D; Lachin JM;
Diabetes Care; 2013 Aug; 36(8):2254-61. PubMed ID: 23690531
[TBL] [Abstract][Full Text] [Related]
11. Rationale and Design for a GRADE Substudy of Continuous Glucose Monitoring.
Larkin ME; Nathan DM; Bebu I; Krause-Steinrauf H; Herman WH; Higgins JM; Tiktin M; Cohen RM; Lund C; Bergenstal RM; Johnson ML; Arends V;
Diabetes Technol Ther; 2019 Dec; 21(12):682-690. PubMed ID: 31393176
[No Abstract] [Full Text] [Related]
12. Correlation between baseline characteristics and clinical outcomes in a large population of diabetes patients treated with liraglutide in a real-world setting in Italy.
Lapolla A; Frison V; Bettio M; Dal Pos M; Rocchini P; Panebianco G; Tadiotto F; Da Tos V; D'Ambrosio M; Marangoni A; Ferrari M; Pianta A; Balzano S; Confortin L; Lamonica M; Marin N; Strazzabosco M; Brun E; Mesturino CA; Simoncini M; Zen F; Bax G; Bonsembiante B; Cardone C; Dal Frà MG; Gallo A; Masin M; Piarulli F; Sartore G; Simioni N
Clin Ther; 2015 Mar; 37(3):574-84. PubMed ID: 25626486
[TBL] [Abstract][Full Text] [Related]
13. Impact of Insulin Sensitivity and β-Cell Function Over Time on Glycemic Outcomes in the Glycemia Reduction Approaches in Diabetes: A Comparative Effectiveness Study (GRADE): Differential Treatment Effects of Dual Therapy.
Utzschneider KM; Younes N; Butera NM; Balasubramanyam A; Bergenstal RM; Barzilay J; DeSouza C; DeFronzo RA; Elasy T; Krakoff J; Kahn SE; Rasouli N; Valencia WM; Sivitz WI;
Diabetes Care; 2024 Apr; 47(4):571-579. PubMed ID: 38190619
[TBL] [Abstract][Full Text] [Related]
14. Glycemic Control in Insulin-Treated Patients With Type 2 Diabetes: Empowerment Perceptions and Diabetes Distress as Important Determinants.
Chen SY; Hsu HC; Wang RH; Lee YJ; Hsieh CH
Biol Res Nurs; 2019 Mar; 21(2):182-189. PubMed ID: 30585081
[TBL] [Abstract][Full Text] [Related]
15. Self-efficacy mediates the associations of diabetes distress and depressive symptoms with type 2 diabetes management and glycemic control.
Gao Y; Xiao J; Han Y; Ji J; Jin H; Mawen DG; Zhong Y; Lu Q; Zhuang X; Ma Q
Gen Hosp Psychiatry; 2022; 78():87-95. PubMed ID: 35932599
[TBL] [Abstract][Full Text] [Related]
16. Effect of bromocriptine-QR on glycemic control in subjects with uncontrolled hyperglycemia on one or two oral anti-diabetes agents.
Vinik AI; Cincotta AH; Scranton RE; Bohannon N; Ezrokhi M; Gaziano JM
Endocr Pract; 2012; 18(6):931-43. PubMed ID: 23186965
[TBL] [Abstract][Full Text] [Related]
17. Short-term intensive insulin therapy could be the preferred option for new onset Type 2 diabetes mellitus patients with HbA1c > 9.
Weng J
J Diabetes; 2017 Oct; 9(10):890-893. PubMed ID: 28661564
[TBL] [Abstract][Full Text] [Related]
18. Risk Factors for Nocturnal Hypoglycemia in Insulin-treated Patients With Type 2 Diabetes: A Secondary Analysis of Observational Data Derived From an Integrated Clinical Trial Database.
Bae JP; Duan R; Fu H; Hoogwerf BJ
Clin Ther; 2017 Sep; 39(9):1790-1798.e7. PubMed ID: 28781218
[TBL] [Abstract][Full Text] [Related]
19. HbA1c After a Short Period of Monotherapy With Metformin Identifies Durable Glycemic Control Among Adolescents With Type 2 Diabetes.
Zeitler P; Hirst K; Copeland KC; El Ghormli L; Levitt Katz L; Levitsky LL; Linder B; McGuigan P; White NH; Wilfley D;
Diabetes Care; 2015 Dec; 38(12):2285-92. PubMed ID: 26537182
[TBL] [Abstract][Full Text] [Related]
20. Effect of Flash Glucose Monitoring on Glycemic Control, Hypoglycemia, Diabetes-Related Distress, and Resource Utilization in the Association of British Clinical Diabetologists (ABCD) Nationwide Audit.
Deshmukh H; Wilmot EG; Gregory R; Barnes D; Narendran P; Saunders S; Furlong N; Kamaruddin S; Banatwalla R; Herring R; Kilvert A; Patmore J; Walton C; Ryder REJ; Sathyapalan T
Diabetes Care; 2020 Sep; 43(9):2153-2160. PubMed ID: 32669277
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
